Arcadia Biosciences Inc. (RKDA)
NASDAQ: RKDA
· Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.35
-1.36%
Pre-market: Aug 15, 2025, 08:00 AM EDT
Arcadia Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.2M | 1.22M | 1.54M | 1.31M | 1.25M | 1.17M | 1.6M | 1.39M | 1.51M | 1M | 1.88M | 3.86M | 3.22M | 2.17M | 2.38M | 1.41M | 828K |
Cost of Revenue | 682K | 827K | 1.03M | 633K | 820K | 670K | 1.1M | 981K | 825K | 1.55M | 1.34M | 3.45M | 3.46M | 3.75M | 2.51M | 1.59M | 856K |
Gross Profit | 518K | 389K | 505K | 673K | 435K | 500K | 495K | 408K | 684K | -552K | 534K | 411K | -238K | -1.58M | -135K | -182K | -28K |
Operating Income | 530K | -2.28M | -1.76M | 1.98M | -3.03M | -3.25M | -3.24M | -3.79M | -4.05M | -5.83M | -4.56M | -4.6M | -4.62M | -13.8M | -8.71M | -7.68M | -5.33M |
Interest Income | 207K | 354K | 233K | 150K | 45K | 157K | 133K | 207K | 198K | 166K | 95K | 30K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.6M | -4.03M | -1.18M | 1.85M | -2.42M | -2.62M | -2.48M | 819K | -4.05M | -4.32M | -2.88M | -3.8M | -4.61M | -9.56M | -2.83M | -5.42M | 1.68M |
Net Income | 2.6M | -4.06M | -1.61M | 1.06M | -2.42M | -2.85M | -2.57M | 823K | -3.85M | -4.33M | -2.88M | -3.78M | -4.47M | -9.28M | -2.17M | -5.26M | 2.06M |
Selling & General & Admin | 1.74M | 2.65M | 2.24M | 2.68M | 3.19M | 3.42M | 3.44M | 3.81M | 4.39M | 4.21M | 4.83M | 4.65M | 4.35M | 6.19M | 6.31M | 6.37M | 4.07M |
Research & Development | n/a | 13K | 24K | 10K | 272K | 332K | 305K | 391K | 359K | 500K | 255K | 359K | 395K | 561K | 1.04M | 1.13M | 1.16M |
Other Expenses | n/a | n/a | n/a | n/a | 3K | 12K | 17K | -13K | 32K | 20K | n/a | -44K | 14K | n/a | -7K | n/a | n/a |
Operating Expenses | 1.74M | 2.67M | 2.27M | 2.69M | 3.46M | 3.75M | 3.75M | 4.21M | 4.75M | 4.71M | 5.09M | 5.01M | 4.74M | 6.75M | 7.35M | 7.5M | 5.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 194K | n/a | n/a | 1K | n/a | 15K | 1K | 9K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.35M | n/a | n/a | -769K |
Cost & Expenses | 2.42M | 3.5M | 3.3M | 3.33M | 4.28M | 4.42M | 4.85M | 5.19M | 5.58M | 6.27M | 6.43M | 8.46M | 8.2M | 10.5M | 9.86M | 9.09M | 6.08M |
Income Tax Expense | n/a | 8K | 430K | n/a | n/a | 7K | n/a | 1K | -198K | 13K | 1K | -20K | n/a | 1K | 1K | n/a | n/a |
Shares Outstanding (Basic) | 1.37M | 1.36M | 1.36M | 1.36M | 1.36M | 1.29M | 1.36M | 1.36M | 864.39K | 616.08K | 597.29K | 554.63K | 554.67K | 22.18M | 543.75K | 543.63K | 474.26K |
Shares Outstanding (Diluted) | 1.37M | 1.36M | 1.36M | 1.36M | 1.36M | 1.29M | 1.36M | 1.36M | 864.39K | 616.08K | 613.81K | 554.72K | 554.67K | 22.18M | 554.43K | 543.63K | 476.07K |
EPS (Basic) | 1.90 | -1.18 | -1.18 | 0.78 | -1.78 | -2.22 | -1.89 | 0.60 | -4.45 | -7.03 | -4.82 | -6.81 | -8.07 | -0.42 | -4 | -9.68 | 4.40 |
EPS (Diluted) | 1.90 | -1.18 | -1.18 | 0.78 | -1.78 | -2.22 | -1.89 | 0.60 | -4.45 | -7.03 | -4.69 | -6.81 | -8.07 | -0.42 | -3.92 | -9.68 | 4.40 |
EBITDA | 530K | -2.26M | -1.75M | -1.99M | -2.98M | -2.75M | -3.16M | -1.39M | -3.81M | -4.71M | -3.9M | -3.78M | -4.82M | -9.35M | -7.18M | -7.68M | -5M |
EBIT | n/a | -2.28M | -1.76M | -2.02M | -3.03M | -3.25M | -3.25M | -1.45M | -3.89M | -5.27M | -3.99M | -3.8M | -4.98M | -9.56M | -7.49M | -7.68M | 1.69M |
Depreciation & Amortization | n/a | 21K | 7K | 34K | 228K | 222K | 267K | 244K | 251K | 284K | 356K | 395K | 328K | 209K | 304K | 276K | 256K |